Clinical and dosimetric factors for symptomatic radiation pneumonitis after stereotactic body radiotherapy for early-stage non-small cell lung cancer
Open Access
- 2 June 2023
- journal article
- research article
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 41, 100648
Abstract
No abstract availableKeywords
Funding Information
- Nagoya Shiritsu Daigaku (2213003)
This publication has 31 references indexed in Scilit:
- Clinical and Dosimetric Predictors of Radiation Pneumonitis in a Large Series of Patients Treated With Stereotactic Body Radiation Therapy to the LungInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- A Dose–Volume Analysis of Radiation Pneumonitis in Non–Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation TherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor sizeRadiation Oncology, 2010
- Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Carcinoma: Four-Year Results of a Prospective Phase II StudyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchusLung Cancer, 2009
- Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapyActa Oncologica, 2009
- Clinical Outcome of Stage III Non-small-cell Lung Cancer Patients After Definitive RadiotherapyLung, 2007
- Exceptionally high incidence of symptomatic grade 2–5 radiation pneumonitis after stereotactic radiation therapy for lung tumorsRadiation Oncology, 2007
- Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung CancerJournal of Clinical Oncology, 2006